Related Experiment Video

Updated: Mar 1, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Interaction of molecular alterations with immune response in melanoma

Robert A Szczepaniak Sloane1, Vancheswaran Gopalakrishnan1, Sangeetha M Reddy2

  • 1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer
|May 26, 2017
PubMed

Insights

Advances in melanoma treatment include targeted therapies and immunotherapies, but resistance remains a challenge. Understanding melanoma mutations and resistance mechanisms is crucial for improving patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Melanoma treatment has advanced with targeted therapies and immunotherapies, leading to FDA-approved regimens for stage IV disease.
  • Therapeutic resistance to these agents is a significant clinical challenge.
  • Reliable biomarkers for predicting response and resistance are currently lacking.

Purpose of the Study:

  • To discuss the molecular mechanisms underlying therapeutic resistance in melanoma.
  • To explore the interplay between melanoma mutations, immune effects, and treatment resistance.
  • To highlight potential strategies for overcoming resistance and improving patient survival.

Main Methods:

  • Review of preclinical studies and translational research.
  • Analysis of molecular mechanisms of therapeutic resistance.
  • Discussion of the immune effects of common melanoma mutations.

Main Results:

  • Mechanistic insights are emerging from ongoing research.
  • Understanding the immune effects of mutations is critical for immunotherapy.
  • Molecular mechanisms of resistance to immunotherapy are being elucidated.

Conclusions:

  • Further research into melanoma mutations and resistance mechanisms is essential.
  • Developing strategies to overcome therapeutic resistance can enhance patient survival.
  • A comprehensive understanding of these factors is key to advancing melanoma treatment.
Keywords:
B-Raf proto-oncogene serine/threonine kinase (BRAF)catenin-β 1 (CTNNB1)combination therapyguanosine-triphosphate guanyltransferase (GTPase)immunotherapymelanomaneoantigenneuroblastoma rat sarcoma viral oncogene homolog (NRAS)personalized medicinephosphatase and tensin homolog (PTEN)targeted therapy

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K